查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球哺乳动物细胞发酵技术市场规模研究与预测（按类型、按应用、最终用途和区域分析），2023-2030 年
市场调查报告书
商品编码
1381797

全球哺乳动物细胞发酵技术市场规模研究与预测（按类型、按应用、最终用途和区域分析），2023-2030 年

Global Mammalian Cell Fermentation Technology Market Size Study & Forecast, by Type, By Application, By End-use and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2022年全球哺乳动物细胞发酵技术市场价值约为394.9亿美元，预计在2023-2030年预测期内将以超过8.64%的成长率成长。哺乳动物细胞发酵广泛用于製造各种生物相似药、酵素、疫苗和其他生物製剂。这是生物製药发展的重要一步。哺乳动物细胞在体外由干细胞产生后，在生物反应器中培养发酵。在此过程中，细胞透过多种代谢途径产生重要的副产物。哺乳动物细胞发酵技术市场的推动因素包括慢性病盛行率不断上升、对新型安全疗法的需求不断增长以及对生物製剂和生物相似药的需求不断增长。

此外，包括癌症在内的各种慢性疾病的盛行率不断上升正在推动市场成长，因为癌症治疗通常涉及使用单株抗体、治疗蛋白和疫苗等生物製剂。哺乳动物细胞发酵是生产这些复杂生物製品的关键方法。由于癌症盛行率的上升，对生物製品的需求增加，这反过来又推动了对哺乳动物细胞发酵技术的需求。根据国际癌症研究机构 (IARC) 估计，2021 年全球癌症负担将增加，新增病例约 190 万例，预计到 2040 年将新增 2750 万例因此，这一因素正在推动个性化药物开发的需求，从而导致市场成长，对生物製剂和生物相似药的需求正在推动哺乳动物细胞发酵技术的市场。这些疗法对于解决许多疾病至关重要，例如癌症、自体免疫疾病和各种慢性疾病。 2022 年5 月，Biocon Biologics Ltd. 和Viatris Inc. 的Abevmy（贝伐珠单抗）获得加拿大卫生部的批准，Abevmy（贝伐珠单抗）是罗氏Avastin（贝伐珠单抗）的生物仿製药，适用于四种癌症适应症。因此，生物製剂和生物相似药的不断发展正在推动市场成长。此外，不断进步的技术进步以及製药公司不断增加的研发支出正在为市场创造新的机会。然而，与技术开发相关的高成本正在限制 2023-2030 年预测期内的市场成长。

全球哺乳动物细胞发酵技术市场研究考虑的关键区域包括亚太地区、北美、欧洲、拉丁美洲以及中东和非洲。由于该地区强大的生物製药行业影响力、支持性的政府法规以及发达的医疗保健基础设施，北美将在 2022 年占据市场主导地位，占据最大的市场份额。此外，对生物製品和生物相似药的需求增加以及慢性病盛行率的上升也促进了该地区市场的扩张。由于患者人数众多、对生物药品的需求不断增加、政府支持生物技术研究和开发的倡议以及合约製造组织 (CMO) 的增长等因素，预计亚太地区将在预测期内成为增长最快的地区。该地区正在推动这一扩张。

研究的目的是确定近年来不同细分市场和国家的市场规模，并预测未来几年的价值。该报告旨在纳入参与研究的国家内该行业的定性和定量方面。

该报告还提供了有关驱动因素和挑战等关键方面的详细信息，这些因素将决定市场的未来成长。此外，它还纳入了利害关係人投资的微观市场的潜在机会，以及对主要参与者的竞争格局和产品供应的详细分析。

目录

第 1 章：执行摘要

  • 市场概况
  • 2020-2030 年全球与细分市场估计与预测
    • 2020-2030 年哺乳动物细胞发酵技术市场（按地区）
    • 2020-2030 年哺乳动物细胞发酵技术市场（按类型）
    • 2020-2030 年哺乳动物细胞发酵技术市场（按应用）
    • 哺乳动物细胞发酵技术市场（按最终用途），2020-2030 年
  • 主要趋势
  • 估算方法
  • 研究假设

第 2 章：全球哺乳动物细胞发酵技术市场定义与范围

  • 研究目的
  • 市场定义和范围
    • 产业演变
    • 研究范围
  • 研究考虑的年份
  • 货币兑换率

第三章：全球哺乳动物细胞发酵技术市场动态

  • 哺乳动物细胞发酵技术市场影响分析（2020-2030）
    • 市场驱动因素
      • 慢性病盛行率不断上升
      • 对新颖且安全的疗法的需求不断增加
      • 对生物製剂和生物相似药的需求不断增长
    • 市场挑战
      • 哺乳动物细胞发酵技术成本高
      • 严格的政府法规
    • 市场机会
      • 技术进步
      • 增加研发支出

第 4 章：全球哺乳动物细胞发酵技术市场：产业分析

  • 波特的五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争竞争
  • 波特的五力影响分析
  • PEST分析
    • 政治的
    • 经济的
    • 社会的
    • 技术性
    • 环境的
    • 合法的
  • 顶级投资机会
  • 最佳制胜策略
  • COVID-19 影响分析
  • 颠覆性趋势
  • 产业专家视角
  • 分析师推荐与结论

第 5 章：全球哺乳动物细胞发酵技术市场（按类型）

  • 市场概况
  • 全球哺乳动物细胞发酵技术市场按类型、性能-潜力分析
  • 2020-2030 年全球哺乳动物细胞发酵技术市场估计与预测（按类型）
  • 哺乳动物细胞发酵技术市场細項分析
    • 仓鼠卵巢 (CHO) 细胞发酵
    • 人类胚胎肾 (HEK) 细胞发酵
    • 小仓鼠肾 (BHK) 细胞发酵
    • 鼠骨髓瘤细胞发酵
    • 其他的

第 6 章：全球哺乳动物细胞发酵技术市场（按应用）

  • 市场概况
  • 全球哺乳动物细胞发酵技术市场按应用、性能-潜力分析
  • 2020-2030 年全球哺乳动物细胞发酵技术市场估计及应用预测
  • 哺乳动物细胞发酵技术市场細項分析
    • 单株抗体
    • 重组蛋白
    • 疫苗
    • 荷尔蒙
    • 酵素
    • 其他的

第 7 章：全球哺乳动物细胞发酵技术市场（依最终用途）

  • 市场概况
  • 全球哺乳动物细胞发酵技术市场（依最终用途、性能）-潜力分析
  • 2020-2030 年全球哺乳动物细胞发酵技术市场估计与最终用途预测
  • 哺乳动物细胞发酵技术市场細項分析
    • 生物製药公司
    • CMO 和 CDMO
    • 学术及研究机构

第 8 章：全球哺乳动物细胞发酵技术市场，区域分析

  • 领先国家
  • 顶尖新兴国家
  • 哺乳动物细胞发酵技术市场，区域市场概况
  • 北美洲
    • 我们
      • 2020-2030 年型别细分估计与预测
      • 2020-2030 年应用细分估计与预测
      • 2020-2030 年最终用途细分估计与预测
    • 加拿大
  • 欧洲哺乳动物细胞发酵技术市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太哺乳动物细胞发酵技术市场概况
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲哺乳动物细胞发酵技术市场概况
    • 巴西
    • 墨西哥
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区

第 9 章：竞争情报

  • 重点企业SWOT分析
    • 公司1
    • 公司2
    • 公司3
  • 顶级市场策略
  • 公司简介
    • Thermo Fisher Scientific, Inc.
      • 关键讯息
      • 概述
      • 财务（视数据可用性而定）
      • 产品概要
      • 最近的发展
    • Merck KGaA
    • Danaher Corporation
    • Lonza Group
    • Hoffmann-La Roche Ltd
    • Sartorius AG
    • AstraZeneca
    • Bristol-Myers Squibb
    • Amgen Inc.
    • Gilead Sciences Inc.

第 10 章：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场预测
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Mammalian Cell Fermentation Technology Market is valued at approximately USD 39.49 billion in 2022 and is anticipated to grow with a growth rate of more than 8.64% over the forecast period 2023-2030. Mammalian cell fermentation, is widely used to create a variety of biosimilars, enzymes, vaccines, and other biologics. It is an essential step in the development of biopharmaceuticals. Mammalian cells are cultured in a bioreactor for fermentation after being produced in vitro from stem cells. The essential byproducts are produced during this process by the cells using a variety of metabolic pathways. The market for Mammalian Cell Fermentation Technology is driven due to factors such as growing prevalence of chronic diseases, growing need for novel and secure therapies and the growing demand for biologics and biosimilars.

Additionally, the rising prevalence of various chronic diseases including cancer is driving the market growth as cancer treatment often involves the use of biologics such as monoclonal antibodies, therapeutic proteins, and vaccines. Mammalian cell fermentation is a crucial method for producing these complex biologics. The demand for biologics rises due to the rising prevalence of cancer, which, in turn, drives the need for mammalian cell fermentation technology. According to the International Agency for Research on Cancer (IARC), it is estimated that there was an increase in the global burden of cancer in 2021 approximately 1.9 million new cases have been recorded, which is projected to account for 27.5 million new cases by 2040. Thus, this factor is propelling the demand for the development of personalized medicines, resulting in market growth, The demand for biologics and biosimilars is driving the market for mammalian cell fermentation technology. These therapies are essential for addressing a number of disorders, such as cancer, autoimmune diseases, and various chronic diseases. In May 2022, Biocon Biologics Ltd. and Viatris Inc. received approval from Health Canada for Abevmy (bevacizumab), a biosimilar to Roche's Avastin (bevacizumab), across four cancer indications. Consequentially, the rising development of biologics and biosimilars is driving market growth. Furthermore, rising technological advancement, as well as the increasing research and development spending by pharmaceutical companies are creating new opportunities to the market. However, the high cost associated with the development of technology is restraining the market growth in the forecast period 2023-2030.

The key regions considered for the Global Mammalian Cell Fermentation Technology Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the region's strong biopharmaceutical industry presence, supportive government regulations, and well-developed healthcare infrastructure. Additionally, the increased demand for biologics and biosimilars as well as the rising prevalence of chronic diseases have contributed to the expansion of the market in the region. Asia Pacific is expected to a fastest growing region during the forecast period, owing to factors such as a big patient population, increasing demand for biologic pharmaceuticals, government initiatives to support biotechnology research and development, and a growth in contract manufacturing organizations (CMOs) in the region, are driving this expansion.

Major market player included in this report are:

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Lonza Group
  • Hoffmann-La Roche Ltd
  • Sartorius AG
  • AstraZeneca
  • Bristol-Myers Squibb
  • Amgen Inc.
  • Gilead Sciences Inc.

Recent Developments in the Market:

  • In January 2023, Fosun Pharma and Shanghai Henlius Biotech announced their agreement for the marketing of serplulimab, an anti-PD-1 monoclonal antibody . The agreement is anticipated to broaden Fosun Pharma's biologics portfolio, as well as its manufacturing and development capabilities, in this quickly expanding market.

Global Mammalian Cell Fermentation Technology Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Type, Application, End Use, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Hamster Ovary (CHO) Cell Fermentation
  • Human Embryonic Kidney (HEK) Cell Fermentation
  • Baby Hamster Kidney (BHK) Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Others

By Application:

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Hormones
  • Enzymes
  • Others

By End Use:

  • Biopharmaceutical Companies
  • CMOs & CDMOs
  • Academic & Research Institutes

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Mammalian Cell Fermentation Technology Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Mammalian Cell Fermentation Technology Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Mammalian Cell Fermentation Technology Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Mammalian Cell Fermentation Technology Market, by End Use, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Mammalian Cell Fermentation Technology Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Mammalian Cell Fermentation Technology Market Dynamics

  • 3.1. Mammalian Cell Fermentation Technology Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of chronic diseases
      • 3.1.1.2. Increasing need for novel and secure therapies
      • 3.1.1.3. Growing demand for biologics and biosimilars
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of mammalian cell fermentation technology
      • 3.1.2.2. Stringent government regulations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancement
      • 3.1.3.2. Increasing research and development spending

Chapter 4. Global Mammalian Cell Fermentation Technology Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Mammalian Cell Fermentation Technology Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Mammalian Cell Fermentation Technology Market by Type, Performance - Potential Analysis
  • 5.3. Global Mammalian Cell Fermentation Technology Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Mammalian Cell Fermentation Technology Market, Sub Segment Analysis
    • 5.4.1. Hamster Ovary (CHO) Cell Fermentation
    • 5.4.2. Human Embryonic Kidney (HEK) Cell Fermentation
    • 5.4.3. Baby Hamster Kidney (BHK) Cell Fermentation
    • 5.4.4. Murine Myeloma Cell Fermentation
    • 5.4.5. Others

Chapter 6. Global Mammalian Cell Fermentation Technology Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Mammalian Cell Fermentation Technology Market by Application, Performance - Potential Analysis
  • 6.3. Global Mammalian Cell Fermentation Technology Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Mammalian Cell Fermentation Technology Market, Sub Segment Analysis
    • 6.4.1. Monoclonal Antibodies
    • 6.4.2. Recombinant Proteins
    • 6.4.3. Vaccines
    • 6.4.4. Hormones
    • 6.4.5. Enzymes
    • 6.4.6. Others

Chapter 7. Global Mammalian Cell Fermentation Technology Market, by End Use

  • 7.1. Market Snapshot
  • 7.2. Global Mammalian Cell Fermentation Technology Market by End Use, Performance - Potential Analysis
  • 7.3. Global Mammalian Cell Fermentation Technology Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
  • 7.4. Mammalian Cell Fermentation Technology Market, Sub Segment Analysis
    • 7.4.1. Biopharmaceutical Companies
    • 7.4.2. CMOs & CDMOs
    • 7.4.3. Academic & Research Institutes

Chapter 8. Global Mammalian Cell Fermentation Technology Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Mammalian Cell Fermentation Technology Market, Regional Market Snapshot
  • 8.4. North America Mammalian Cell Fermentation Technology Market
    • 8.4.1. U.S. Mammalian Cell Fermentation Technology Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Mammalian Cell Fermentation Technology Market
  • 8.5. Europe Mammalian Cell Fermentation Technology Market Snapshot
    • 8.5.1. U.K. Mammalian Cell Fermentation Technology Market
    • 8.5.2. Germany Mammalian Cell Fermentation Technology Market
    • 8.5.3. France Mammalian Cell Fermentation Technology Market
    • 8.5.4. Spain Mammalian Cell Fermentation Technology Market
    • 8.5.5. Italy Mammalian Cell Fermentation Technology Market
    • 8.5.6. Rest of Europe Mammalian Cell Fermentation Technology Market
  • 8.6. Asia-Pacific Mammalian Cell Fermentation Technology Market Snapshot
    • 8.6.1. China Mammalian Cell Fermentation Technology Market
    • 8.6.2. India Mammalian Cell Fermentation Technology Market
    • 8.6.3. Japan Mammalian Cell Fermentation Technology Market
    • 8.6.4. Australia Mammalian Cell Fermentation Technology Market
    • 8.6.5. South Korea Mammalian Cell Fermentation Technology Market
    • 8.6.6. Rest of Asia Pacific Mammalian Cell Fermentation Technology Market
  • 8.7. Latin America Mammalian Cell Fermentation Technology Market Snapshot
    • 8.7.1. Brazil Mammalian Cell Fermentation Technology Market
    • 8.7.2. Mexico Mammalian Cell Fermentation Technology Market
  • 8.8. Middle East & Africa Mammalian Cell Fermentation Technology Market
    • 8.8.1. Saudi Arabia Mammalian Cell Fermentation Technology Market
    • 8.8.2. South Africa Mammalian Cell Fermentation Technology Market
    • 8.8.3. Rest of Middle East & Africa Mammalian Cell Fermentation Technology Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Thermo Fisher Scientific, Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Merck KGaA
    • 9.3.3. Danaher Corporation
    • 9.3.4. Lonza Group
    • 9.3.5. Hoffmann-La Roche Ltd
    • 9.3.6. Sartorius AG
    • 9.3.7. AstraZeneca
    • 9.3.8. Bristol-Myers Squibb
    • 9.3.9. Amgen Inc.
    • 9.3.10. Gilead Sciences Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Mammalian Cell Fermentation Technology Market, report scope
  • TABLE 2. Global Mammalian Cell Fermentation Technology Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Mammalian Cell Fermentation Technology Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Mammalian Cell Fermentation Technology Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Mammalian Cell Fermentation Technology Market estimates & forecasts by End Use 2020-2030 (USD Billion)
  • TABLE 6. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Mammalian Cell Fermentation Technology Market
  • TABLE 71. List of primary sources, used in the study of global Mammalian Cell Fermentation Technology Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Mammalian Cell Fermentation Technology Market, research methodology
  • FIG 2. Global Mammalian Cell Fermentation Technology Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Mammalian Cell Fermentation Technology Market, key trends 2022
  • FIG 5. Global Mammalian Cell Fermentation Technology Market, growth prospects 2023-2030
  • FIG 6. Global Mammalian Cell Fermentation Technology Market, porters 5 force model
  • FIG 7. Global Mammalian Cell Fermentation Technology Market, pest analysis
  • FIG 8. Global Mammalian Cell Fermentation Technology Market, value chain analysis
  • FIG 9. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Mammalian Cell Fermentation Technology Market, regional snapshot 2020 & 2030
  • FIG 15. North America Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable